ADIPOQ and metabolic syndrome: In patients with dyslipidemia, ADIPOQ mRNA was decreased in EAT (2.7-fold, p = 0.021) and PVAT (3.6-fold, p = 0.033), however, did not differ in SAT (Figure 3).